Abul Bashar Ripon Khalipha 1*
1Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100

Abstract
NTDs have long been neglected in global health. They’re linked to
poverty and produce local illness burdens but aren’t global priority. At
the turn of the millennium, NTDs were expected to affect 2 billion
people, equivalent to HIV/AIDS, tuberculosis, or malaria. Global
action was needed.In the early 2000s, the WHO developed a five
pronged plan to address NTDs as a collection of diseases. Strong
public-private partnerships in the pharmaceutical sector have
enhanced access to NTD medications. The combination of a WHO
NTD roadmap with defined 2020 targets and game-changing partner
pledges in the London Declaration on Neglected Tropical Diseases
has led to extraordinary success in implementing large-scale
preventative treatment, case management, and care of NTDs. In the
next decade, mainstreaming NTD interventions into Universal Health
Coverage and coordinating with other sectors to tackle poverty and
scale up transmission-breaking initiatives will be difficult. Chinese
expertise with eliminating numerous NTDs, along with poverty
reduction and intersectoral activity, can serve as a model for the latter.
The international community must keep a specific focus on NTDs to
steer this global response, oversee the scaling up and sustainability of
NTD interventions, and create fresh products and implementation
techniques for lagging NTDs. The year 2020 will be significant for the
future of the worldwide response against NTDs. A new 2021–2030The
NTD roadmap will be released, and the London Declaration pledges
will need to be updated. In the next decade, the global response should
build on today’s successes, align with new global healthand
development frameworks, and mobilize enough resources to take the
endeavor through until 2030. N eglected tropical diseases, poverty-related diseases, global health priority, integrated control